Phase II ABT-888 With Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Primary Peritoneal Cancer
Related studies linked through entity extraction aliases.
Panitumumab and Gemcitabine in Relapsed Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)
- Status
- TERMINATED
- Phase
- PHASE3
Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
- Status
- COMPLETED
- Phase
- PHASE1
TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Therapy for Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Paclitaxel in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)
- Status
- COMPLETED
- Phase
- PHASE1
Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2